Persistence, Health Care Resource Utilization, and Costs Among OnabotulinumtoxinA-Treated Patients with Cervical Dystonia in the US
Objective: To compare health care resource utilization (HCRU) and costs among patients with cervical dystonia (CD) in the US who are persistent vs nonpersistent with…Using wearable wireless technology to understand the natural history of adrenomyeloneuropathy in both clinic and home settings: 1-year follow-up in the CYGNET study
Objective: To assess the feasibility of using wearable wireless motion sensors to quantify disease progression in men with adrenomyeloneuropathy (AMN) enrolled in the CYGNET natural…Inhibitory and facilitatory alterations in prodromal and de novo Parkinson’s disease
Objective: The aim of this study was to detect alterations within GABAergic, glutamatergic and cholinergic circuitries in Parkinson’s Disease (PD) patients, including de Novo PD…Botulinum toxin injections for lingual protrusion dystonia: a review of the muscle target and dosage
Objective: The aim of our study was to perform a literature review about the botulinum toxin types, their dosage and muscle target in the treatment…Marked reduction of energy supply due to levodopa treatment in patients with Parkinson’s disease and healthy controls
Objective: To investigate the influence of a standardized, placebo-controlled administration of levodopa on cerebral bioenergetics in patients with Parkinson’s disease (PwPD) and healthy controls (HCs).…Supine hypertension is longitudinally associated with cognitive decline in Parkinson disease independent of orthostatic hypotension
Objective: To determine whether orthostatic hypotension (OH) and/or supine hypertension (SH) are longitudinally associated with cognitive decline in Parkinson disease (PD). Background: Cognitive impairment is…Multiple methods to improve recruitment, enrollment, and retention of study participants for validation of the Fragile X-Associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS)
Objective: Describe multiple methods used to recruit, enroll and retain participants to validate the FXTAS-RS. Background: A clinical outcome assessment (COA) must be developed to…Hypoxia‑induced astrocyte activation and its protective effect on Parkinson’s disease
Objective: In this study, we aimed to investigate whether hypoxic conditions can activate cerebral astrocytes and explore their protective effects on α-synuclein pre-formed fibril (PFF)-treated…Specific Parkinson’s disease phenotype in patients with long term PTSP
Objective: to describe possibly specific clinical phenotype of PD patients who suffered from long-term postraumatic-stress-disorders (PTSD Background: There is enough evidence about the relationship between…Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study
Objective: To assess the progression and predictive value of neuropsychological testing on the development of dementia in idiopathic REM sleep behavior disorder (iRBD). Background: iRBD…
- « Previous Page
- 1
- …
- 173
- 174
- 175
- 176
- 177
- …
- 186
- Next Page »